22 Jul Evotec
Victor Aguilar Lopez, Head of Business Development Cell Therapy
Oct. 5 | 12:00pm | FLW Ballroom G
Northern Germany
(XETRA: EVT)
Evotec is a life sciences company focused on delivering highly effective new therapeutics to patients. The company leverages its multimodality platforms for proprietary projects and pipeline co-creation with partners including pharma, biotech, academics, and other healthcare stakeholders. Our business model is flexible, ranging from service-based support to strategic partnerships. Within cell therapy, Evotec offers a fully integrated end-to-end platform to move iPSC-based projects from inception to the clinic, including in-house GMP manufacturing and GMP gene editing capabilities. Our platform is one of the broadest in the industry. The company focusses on therapeutic indications requiring long term engraftment of cells like regenerative therapies (beta cells, cardiomyocytes, photoreceptors) and immune-modulation therapies (macrophages, T cells). In addition, Evotec provides integrated drug development solutions, covering safety assessment, CMC, process and analytical development, regulatory and clinical services for autologous and allogeneic cell therap